Literature DB >> 8981387

Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.

I Weiner1, E Shadach, R Barkai, J Feldon.   

Abstract

Latent inhibition (LI) refers to retarded conditioning to a stimulus as a consequence of its nonreinforced preexposure. LI is impaired in acute schizophrenic patients and in rats treated with amphetamine. Neuroleptic drugs enhance LI, and this effect is selective and specific for this class of drugs. The present experiments tested the proposition that neuroleptic-induced enhancement of LI stems from decreased capacity of stimulus-preexposed animals to switch responding according to the new stimulus-reinforcement contingency in the conditioning stage. LI was assessed using an off-baseline conditioned emotional response (CER) procedure in rats licking for water, consisting of three stages: preexposure to the-to-be conditioned stimulus, tone; conditioning, in which the preexposed stimulus was paired with a foot-shock; and test, in which LI was indexed by animals' degree of suppression of licking during tone presentation. Whereas in previous studies that demonstrated LI enhancement by neuroleptics, preexposure consisted of 10 to 40 tones, and conditioning included two tone-shock pairings, the present experiments used 40 tone preexposures, followed by an extended conditioning stage with five tone-shock pairings. It was expected that under these conditions no LI effect would be evident in untreated animals, but that animals treated with a neuroleptic drug, either during the entire LI procedure or only in conditioning, would show LI. Experiments 1 and 2 showed that LI was obtained in rats treated with haloperidol (0.1 mg/kg in experiment 1, 0.03 and 0.2 mg/kg in experiment 2) but not in the untreated controls. Experiment 3 showed that the same outcome was obtained when haloperidol (0.1 mg/kg) administration was confined to the conditioning stage. Experiment 4 showed that clozapine (5 mg/kg)-treated animals showed LI when the drug was confined to conditioning, but not to the preexposure stage. The implications of these results for the mechanism of action of neuroleptic drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8981387     DOI: 10.1016/S0893-133X(96)00145-5

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

1.  Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Authors:  Tatiana V Lipina; Oksana Kaidanovich-Beilin; Satish Patel; Min Wang; Steven J Clapcote; Fang Liu; James R Woodgett; John C Roder
Journal:  Synapse       Date:  2011-03       Impact factor: 2.562

2.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

3.  Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs.

Authors:  D Feifel; P D Shilling; J Hillman; M Maisel; J Winfield; G Melendez
Journal:  Behav Brain Res       Date:  2014-10-30       Impact factor: 3.332

Review 4.  The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.

Authors:  Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

5.  Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia.

Authors:  Tatiana Lipina; Viviane Labrie; Ina Weiner; John Roder
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

6.  Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.

Authors:  Inna Gaisler-Salomon; Gretchen M Miller; Nao Chuhma; Sooyeon Lee; Hong Zhang; Farhad Ghoddoussi; Nicole Lewandowski; Stephen Fairhurst; Yvonne Wang; Agnès Conjard-Duplany; Justine Masson; Peter Balsam; René Hen; Ottavio Arancio; Matthew P Galloway; Holly M Moore; Scott A Small; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-06-10       Impact factor: 7.853

7.  Role of basolateral amygdala dopamine in modulating prepulse inhibition and latent inhibition in the rat.

Authors:  C W Stevenson; Alain Gratton
Journal:  Psychopharmacology (Berl)       Date:  2004-04-28       Impact factor: 4.530

8.  Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.

Authors:  L Zuckerman; N Rimmerman; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

9.  Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone.

Authors:  Michal Arad; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2009-01-25       Impact factor: 4.530

10.  Deficits in latent inhibition induced by estradiol replacement are ameliorated by haloperidol treatment.

Authors:  Anne Almey; Nada M Hafez; Arne Hantson; Wayne G Brake
Journal:  Front Behav Neurosci       Date:  2013-10-01       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.